The Insight Partners Latest Research on “Antacid Market Forecast to 2027″ Includes COVID-19 Impact and Global Analysis By Dosage Form (Tablet, Liquid, Others); Drug Class (Proton pump inhibitors, H2 Antagonist, Acid neutralizers); Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) and Geography
“Antacid Market is expected to reach US$ 11,666.83 million by 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027. The report highlights trends prevailing in the global Antacid market, and the drivers and restraints pertaining to the market growth.
Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00016359/
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminum hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.
Market Leaders:
Market leaders operating in the market have undertaken various organic growth strategies in the antacid market. The antacid majorly consists of the players such as Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble among others. Several organic approaches, such as product launches, and expansion in the Antacid, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
Below is the list of the growth strategies done by the players operating in the Antacid market:
Aug-20: Takeda Pharmaceutical Company Limited declared that it has entered into an agreement to divest Takeda Consumer Healthcare Company Limited, a wholly-owned subsidiary of Takeda that operates in the consumer health care market primarily in Japan, to Oscar A-Co KK. This company is funded and managed by The Blackstone Group Inc
Inquire Your Queries at:
https://www.theinsightpartners.com/inquiry/TIPRE00016359/
Dec-2018: GSK and Pfizer entered a joint venture for consumer healthcare businesses. This transaction created a new world-leading Consumer Healthcare. This transaction is expected to close within three years of the closing of the transaction. This venture is expected to help the companies to lead the product categories in the respective markets. The types include Pain Relief, Respiratory, Vitamin and Mineral Supplements, Digestive Health, Skin Health, and Therapeutic Oral Health
Jun-2018: GlaxoSmithKline plc acquired about 36.5% stake in its Consumer Healthcare from Novartis for an estimated value of about US$13 billion. This acquisition has helped the company to strengthen its Consumer Healthcare business worldwide
Geographical Analysis:
In terms of geography, the global antacid market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. North America held the largest market share in 2019. In North America, the U.S. is the largest market for antacid. The growth of the region is attributed to presence of key market players and growing product developments. In addition, growing obesity are further expected to stimulate the growth of Antacid market in North America.
Segments – By Dosage Form:
Based on dosage form, the antacid market is segmented into tablet, liquid, and others. In 2019, the microbial tablet segment held the largest share of the market. The liquid segment is expected to grow at the fastest rate during the forecast period. liquid dosage form is preferred by children and ageing population due to its flavored/palatable taste. Also, presence of major market players such as Procter & Gamble, Pfizer, GSK GROUP and others are offering liquid antacids which is likely to propel the growth of the segment.
Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00016359/
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876